Neuroprotective effect of the Chinese medicine Tiantai No.1 and its molecular mechanism in the senes

来源 :Neural Regeneration Research | 被引量 : 0次 | 上传用户:chenminer
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Tiantai No.1, a Chinese medicine predominantly composed of powdered Rhizoma Gastrodiae, Radix Ginseng, and Ginkgo leaf at a ratio of 2:1:2 and dissolved in pure water, is neuroprotective in animal models of various cognitive disorders, but its molecular mechanism remains unclear. We administered Tiantai No.1 intragastrically to senescence-accelerated mouse prone 8(SAMP8) mice(a model of Alzheimer’s disease) at doses of 50, 100 or 150 mg/kg per day for 8 weeks and evaluated their behavior in the Morris water maze and expression of Alzheimer’s disease-related proteins in the brain. Tiantai No.1 shortened the escape latency in the water maze training trials, and increased swimming time in the target quadrant during the spatial probe test, indicating that Tiantai No.1 improved learning and memory in SAMP8 mice. Immunohistochemistry revealed that Tiantai No.1 restored the proliferation potential of Ki67-positive cells in the hippocampus. In addition, mice that had received Tiantai No.1 had fewer astrocytes, and less accumulation of amyloid-beta and phosphorylated tau. These results suggest that Tiantai No.1 is neuroprotective in the SAMP8 mouse model of Alzheimer’s disease and acts by restoring neuronal number and proliferation potential in the hippocampus, decreasing astrocyte infiltration, and reducing the accumulation of amyloid-beta and phosphorylated tau. Tiantai No.1, a Chinese medicine predominantly composed of powdered Rhizoma Gastrodiae, Radix Ginseng, and Ginkgo leaf at a ratio of 2: 1: 2 and dissolved in pure water, is neuroprotective in animal models of various cognitive disorders, but its molecular mechanism We observed that the symptoms of senescence-accelerated mouse prone 8 (SAMP8) mice (a model of Alzheimer’s disease) at doses of 50, 100 or 150 mg / kg per day for 8 weeks and evaluated their behavior in the Morris water maze and expression of Alzheimer’s disease-related proteins in the brain. Tiantai No.1 shortened the escape latency in the water maze training trials, and increased swimming time in the target quadrant during the spatial probe test, indicating that Tiantai No.1 Improved learning and memory in SAMP8 mice. Immunohistochemistry revealed that Tiantai No.1 restored the proliferation potential of Ki67-positive cells in the hippocampus. In addition, mice that had received Tiantai No.1 had fewer astrocytes, and less accumulation of amyloid-beta and phosphorylated tau. These results suggest that Tiantai No.1 is neuroprotective in the SAMP8 mouse model of Alzheimer’s disease and acts by restoring neuronal number and proliferation potential in the hippocampus, decreasing astrocyte infiltration, and reducing the accumulation of amyloid-beta and phosphorylated tau.
其他文献
糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)是糖尿病最常见的半发症之一,患病率达60%~90%。临床上表现为对称性多发周围神经病变和非对称性单一或多发单神经病变
李昕遥说,她希望以后的每一场比赛都能拿到好名次,因为只有这样,才能让父母不再那么辛苦,才能回报自己的老师、教官和每一个帮助过她的人。踏破铁鞋的默契小时候格外淘气的宋
<正>《中国中医药报》2017年4月14日讯:海南省政府办公厅近日印发《海南省贯彻中医药发展战略规划纲要(2016~2030年)实施方案》,方案提出九项工作内容并分别明确各项任务的责
期刊
1病例摘要例1.张某,女,54岁,以左底节区腔隙性脑梗塞住院。治疗给予口服尼莫地平40mgTid,维生素E0.1Tid,肠溶阿斯匹林25mgqd,同时静点5%葡萄糖500ml加血塞通0.4.qd,3d后病人自觉前胸及及腹部瘙痒难忍,检查前胸、腹部可见...
2015年,宁夏不断加大科技投入力度,设立1亿元企业创新“后补助”专项资金,继续鼓励和引导企业按照市场需求先行投入开展科技创新。据了解,宁夏从2014年开始对企业科技创新实行“后补助”机制,对企业自筹资金开展应用研究、试验发展、成果转化等技术创新活动的,将按照企业研究和试验发展投入给予后补助,自治区和市县(区)财政各按50%比例承担,单个企业一次性补助最高可达500万元。宁夏2014年科技后补助项
近年来,随着人民生活水平的不断提高,糖尿病的患病情况有逐渐增高的趋势,而且糖尿病危害着职工的身体健康,直接影响了生产力。因此,我们进行此项调查,了解职工中糖尿病的患
[目的]建立医院制剂补脾强力膏的微生物限度检查方法。[方法]按照《中华人民共和国药典》2010年版(一部)采用常规法、培养基稀释法对补脾强力膏的细菌、霉菌及酵母菌计数测定
本文论述了复合土工膜在南水北调干渠防渗处理中的应用,采用复合土工膜对干渠边坡的防渗处理,防渗效果良好,具有推广价值。 This paper discusses the application of compo
一个不会画画的选手不是一个好裁缝一个不懂音乐的设计师不是一个好舞者……等等!这就晕了吗?要知道,对于一位生活在今天的职业舞者来说,画风可绝不会只有一种!想知道他们身
我科自1996年6月至今,对收治40例低钾性肌无力患者,并就低钾原因补钾的问题作进一步探讨.旨在共同探讨。1临床资料1.1一般资料:40例中,男26例,女14例.年龄16~30岁,所有患者均为工厂工人